Bibliography
- RAAMA CS, SHIRODE AR, MUNDADA AS, KADAM VJ: Nutraceuticals – an e.g., era in the treatment and prevention of cardiovascular diseases. Curr. Pharm. Biotechnol. (2006) 7:15-23.
- HU FB, WILLETT WC: Optimal diets for prevention of coronary hearth disease. JAMA (2002)288:2569-2578.
- DAVIES MJ, RICHARDSON PJ, WOOLF N, KATZ DR, MANN J: Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br. Heart J. (1993) 69:337-381.
- DAVIES M: Acute coronary thrombosis: the role of plaque disruption and its initiation and prevention. Eur. Heart J. (1995) 16:3-7.
- DAVIES M: The composition of coronary artery plaque. N. Engl. J. Med. (1997) 336:1312-1313.
- RICCIONI G, DE SANTIS A, CERASA V et al.: Atherosclerotic plaque formation and risk factors. Int. J. Immunopathol. Pharmacol. (2003) 16:25-31.
- HASDAI D, BEHAR S, WALLENTIN L et al.: A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur. Heart J. (2002) 23:1190-1201.
- 1998 Heart and stroke statistical update. Dallas, TX, American Heart Association (1997):1-29.
- MURABITO JM, EVANS JC, LARSON MG, LEVY D: Prognosis after the onset of coronary heart disease. An investigation of differencies in outcome between the sexses according to initial coronary disease presentation. Circulation (1993) 88:2548-2555.
- NATIONAL CENTER FORHEALTH STATISTICS, DIVISION OF VITAL STATISTICS: Public use data tapes for US mortality, 1970 to 1995 and provisional tubulations for 1996. Hyattsville, MD, National Center for Health Statistics (1997).
- NATIONAL HEART, LUNGAND BLOOD INSTITUTE: Morbidity and mortality: 1996 chartbook on cardiovascular, lung and blood diseases. National Institutes of Health, Bethesda, USA (1996).
- MURRAJ CJL, LOPEZ AD: Alternative projections of mortality and disability by cause 1990 – 1992: Global Burden of Disease Study. Lancet (1997) 349:1498-1503.
- HARRISON RA, HOLT D, PATTISON DJ, ELTON PJ: Are those in need taking dietary supplements? A survey of 21923 adults. Br. J. Nutr. (2004) 91:617-623.
- KRAUSS RM, ECHEL RH, HOWARD B et al.: AHA Dietary Guidelines revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Hearth Association. Circulation (2000) 102:2284-2299.
- LAWLOR DA, DAVEY SMITH G, KUNDU D, BRUCKDORFER KR, EBRAHIM S: Those confounded vitamins: what can we learned from the differences between observational versus randomized trial evidence. Lancet (2004) 363:1660-1661.
- HASNIAN BI, MOORADIAN AD: Recent trials of antioxidants therapy: what should we be telling our patients? Cleve. Clin. J. Med. (2004) 71:327:334.
- FERRARI R, GUARDIGLI G, MELE D, PERCOCO GF, CECONI G, CURELLO S: Oxidative stress during myocardial ischaemia and heart failure. Curr. Pharm. Des. (2004) 10:1699-1711.
- VIOLI F, LOFFREDO L, MUSELLA L, MARCOCCIA A: Should antioxidant status be considered in interventional trials with antioxidants? Heart (2004) 90:598-602.
- LIBBY P, AIKAWA M, SCHONBECK U: Cholesterol and atherosclerosis. Biochim. Biophys. Acta (2000) 1529:299-309.
- LEY K: The role of selectins in inflammation and disease. Trends Mol. Med. (2003) 9:263-268.
- KULLER LH, TAVEN ND, RUTAN GH, PERPER JA, IVES DG: Marked decline of coronary heart disease mortality in 35-44-year-old white men in Allegenny County, Pennsylvania. Circulation (1989) 80:261-266.
- SCHRODER S: Is the supplementation with antioxidants effective in the treatment of atherosclerosis? Med. Wochenschr. (2004) 129:321-326.
- MONTELEONE CA, SHERMAN AR: Nutrition and asthma. Arch. Intern. Med. (1997) 157:23-34.
- ROCK E, WINKLHOFER-ROOB BM, RIBALTA J et al.: Vitamin A, vitamin E and carotenoid status and metabolism during ageing: functional and nutritional consequences (VITAGE PROJECT). Nutr. Metab. Cardiovasc. Dis. (2001) 11:70-73.
- GORDON T, KANNEL WB: Multiple risk functions for predicting coronary heart disease: the concept, accuracy and application. Am. Heart J. (1982) 103:1031-1039.
- CARR AC, ZHU BZ, FREI B: Potential antiatherogenic mechanisms of ascorbate (vitamin C) and α tocopherol (vitamin E). Circ. Res. (2000) 87:349-354.
- KUCUKBAY H, YAKINCI C, KUCUKBAY FZ, TURGUT M: Serum vitamin A and β-carotene levels in children with recurrent acute respiratory infections and diarrhoea in Malatya. J. Trop. Pediatr. (1997) 43:337-340.
- MAYNE ST: β-carotene, carotenoids, and disease prevention in humans. FASEB J. (1996) 10:690-701.
- MORABIA A, SORENSON A, KUMANYIKA SK, ABBEY H, COHEN BH, CHEE E: Vitamin A cigarette smoking and airway obstruction. Am. Rev. Respir. Dis. (1989) 140:1312-1316.
- BUIJSSE B, FESKENS EJ, SCHLETTWEIN-GSELL D et al.: Plasma carotene and α-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: the Survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA). Am. J. Clin. Nutr. (2005) 82:879-886.
- HENNEKENS CH, ALBERT CM, GODFRIED SL, GAZIANO JM, BURING JE: Physicians Health Study. Lack of effect of long term siupplementation with β-carotene on the incidence of malignant neoplasm and cardiovascular disease. N. Engl. J. Med. (1996) 334:1145-1149.
- OMENN GS, GOODMAN GE, THORNQUIST MD et al.: Hammar β-Carotene and Retinol Efficacy Trial (CARET): effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. (1996) 334:1150-1155.
- KUSHI LH, FOLSOM AR, PRINEAS RJ, MINK PJ, WU Y, BOSTICK RM: Dietary antioxidant vitamins and death from coronary hearth disease in postmenopausal women. N. Engl. J. Med. (1996) 334:1156-1162.
- RAPOLA JM, VIRTAMO J, RIPATTI S, HUTTUNEN JK, ALBANES D, TAYLOR PR, HEINONEN OP; ALPHA TOCOPHEROL BETA CAROTENE CANCER PREVENTION STUDY (ATBC): Randomized trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous MI. Lancet (1997) 349:1715-1720.
- ENSTROM JE: Vitamin C intake and mortality among sample of US population. Epidemiology (1992) 3:194-202.
- BLOT WJ, LI JY, TAYLOR HR et al.: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. (1993) 15:1483-1492.
- DIAZ MN: Antioxidants and atherosclerotic hearth disease. N. Engl. J. Med. (1997) 337:408-416.
- ENSTROM JE: Vitamin C intake and mortality among a sample of the United States population. Epidemiology (1992) 3:194-202.
- WILSON TS, DATTA SB, MURREL JS, ANDREWS CT: Relation of vitamin C level to mortality in a geriatric hospital: a study of affect of vitamin C administration. Age Ageing (1973) 2:163-171.
- BOAZ M, SMETANA S, WEINSTEIN T et al.: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet (2000) 356:1213-1218.
- MACHLIN LJ: Handbook of vitamins: nutritional, biochemical, and clinical aspects. Marcel Dekker, Inc., New York, USA (1991) 2:99-144.
- MARQUEZ M, YEPEZ CE, SUTIL-NARAJO R, RINCON M: Basic aspects and measurement of the antioxidat vitamins A and E. Invest. Clin. (2002) 43:191-204.
- ROCK E, WINKLHOFER-ROOB BM, RIBALTA J et al.: Vitamin A, vitamin E and carotenoid status and metabolism during ageing: functional and nutritional consequences (VITAGE PROJECT). Nutr. Metab. Cardiovasc. Dis. (2001) 11:70-73.
- MORIGUCHI S, MURAGA M: Vitamin E and immunity. Vitam. Horm. (2000) 59:305-336.
- BARASI ME: Water soluble vitamins. In: Human nutrition. Arnold publishers, London, UK (1997):171-175.
- DEVARAJ S, HARRIS A, JIALAL I: Modulation of monocyte-macrophage function with α-tocopherol: implications for atherosclerosis. Nutr. Rev. (2002) 60:8-14.
- YOSHIKAWA T, YOSHIDA N: Vitamin E and leukocyte–endothelial cell interactions. Antioxid. Redox. Signal. (2000) 2:821-825.
- ABUDU N, MILLER JJ, ATTAELMANNAN M, LEVINSON SS: Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. Clin. Chim. Acta (2004) 339:11-25.
- KAWACHI I, COLDITZ GA, ASCHERIO A et al.: Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation (1994) 89:1992-1997.
- ELLIS NI, LLOYD B, LLOYD RS, CLAYTON BE : Selenium and vitamin E in relation to risk factors for coronary heart disease. J. Clin. Pathol. (1984) 37:200-206.
- STEPHENS NG, PARSON A, SCHOFIELD PM, KELLY F, CHEESEMAN K, MITCHINSON MJ: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet (1996) 347(9004):781-786.
- SINGH RB, NIAZ MA, RASTOGI SS, RASTOGI S: Usefulness of antioxidants vitamin in suspected-acute myocardial infarction (the Indian Experiment of Infarct Survival-3). Am. J. Cardiol. (1996) 77:232-236.
- NEGRI E, LA VECCHIA C, NOBILI A, D’AVANZO B, BECHI S: Cigarette smoking and acute myocardial infarction. A case-control study from the GISSI-2 trial. GISSI-EFRIM Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto-Epidemiologia dei Fattori di Rischio dell’infarto Miocardico. Eur. J. Epidemiol. (1994) 10:361-366.
- THE HEARTH OUTCOMESPREVENTION EVALUATION STUDY INVESTIGATORS: Vitamin E supplementation and cardiovascular events in high risk patients. N. Engl. J. Med. (2000) 342:154-160.
- KALIORA AC, DEDOUSSIS GV, SCHMIDT H: Dietary antioxidants in preventing atherogenesis. Atherosclerosis (2005) (In Press).
- PHAM DQ, PLAKOGIANNIS R: Vitamin E supplementation in cardiovascular disease and cancer prevention: part 1. Ann. Pharmacother. (2005) 39:1870-1878.
- TRIBBLE DL, AHA SCIENCE ADVISORY: Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and β-carotene: a statement for healthcare professionals from the American Hearth Association. Circulation (1999) 99:591-595.
- MORRIS CD, CARSON S: Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the US Preventive Services Task Force. Ann. Intern. Med. (2003) 139:56-70.
- US PREVENTIVE SERVICESTASK FORCE: Routine vitamin supplementation to prevent cancer and cardiovascular disease. Nutr. Clin. Care (2003) 6:102-107.
- STANNER SA, HUGHES J, KELLY CN, BUTTRISS J: A review of the epidemiological evidence for the ‘antioxidant hypothesis’. Public Health Nutr. (2004) 7:407-422.
- BECKER LB: New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovascul. Res. (2004) 61:461-470.
- MORILLAS-RUIZ JM, VILLEGAS GARCIA JA, LOPEZ FJ, VIDAL-GUEVARA ML, ZAFRILLA P: Effects of polyphenolic antioxidants on exercise-induced oxidative stress. Clin. Nutr. (2006) (In Press).
- KRIS-ETHERTON PM, LEFEVRE M, BEECHER GR, GROSS MD, KEEN CL, ETHERTON TD: Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Ann. Rev. Nutr. (2004) 24:511-538.
- JURANEK I, BEZEK S: Controversy of free radical hypotesis: reactive oxygen species - cause or consequence of tissue injury? Gen. Physiol. Biophys. (2005) 24:263-278.